These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8536121)

  • 1. Randomized, prospective trial of fenoldopam vs sodium nitroprusside in the treatment of acute severe hypertension. Fenoldopam Study Group.
    Panacek EA; Bednarczyk EM; Dunbar LM; Foulke GE; Holcslaw TL
    Acad Emerg Med; 1995 Nov; 2(11):959-65. PubMed ID: 8536121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenoldopam mesylate versus sodium nitroprusside in the acute management of severe systemic hypertension.
    Pilmer BL; Green JA; Panacek EA; Elliot WJ; Murphy MB; Rutherford W; Nara AR
    J Clin Pharmacol; 1993 Jun; 33(6):549-53. PubMed ID: 8103527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous fenoldopam versus sodium nitroprusside in patients with severe hypertension.
    Reisin E; Huth MM; Nguyen BP; Weed SG; Gonzalez FM
    Hypertension; 1990 Feb; 15(2 Suppl):I59-62. PubMed ID: 1967592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fenoldopam versus nitroprusside for the treatment of hypertensive emergency.
    Devlin JW; Seta ML; Kanji S; Somerville AL
    Ann Pharmacother; 2004 May; 38(5):755-9. PubMed ID: 15039472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of fenoldopam mesylate and nitroprusside on left ventricular performance in severe systemic hypertension.
    Hackman BB; Griffin B; Mills M; Ramanathan KB
    Am J Cardiol; 1992 Apr; 69(9):918-22. PubMed ID: 1347965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of intravenous fenoldopam mesylate in the management of severe systemic hypertension.
    Munger MA; Rutherford WF; Anderson L; Hakki AI; Gonzalez FM; Bednarczyk EM; Emmanuel G; Weed SG; Panacek EA; Green JA
    Crit Care Med; 1990 May; 18(5):502-4. PubMed ID: 1970283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative renal effects of intravenous administration of fenoldopam mesylate and sodium nitroprusside in patients with severe hypertension.
    White WB; Halley SE
    Arch Intern Med; 1989 Apr; 149(4):870-4. PubMed ID: 2565105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
    Shusterman NH; Elliott WJ; White WB
    Am J Med; 1993 Aug; 95(2):161-8. PubMed ID: 8102835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials.
    Lacourcière Y; Neutel JM; Schumacher H
    Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenoldopam infusion for the treatment of postoperative hypertension.
    Goldberg ME; Cantillo J; Nemiroff MS; Subramoni J; Muñoz R; Torjman M; Schieren H
    J Clin Anesth; 1993; 5(5):386-91. PubMed ID: 8105829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.
    Tumlin JA; Dunbar LM; Oparil S; Buckalew V; Ram CV; Mathur V; Ellis D; McGuire D; Fellmann J; Luther RR
    Acad Emerg Med; 2000 Jun; 7(6):653-62. PubMed ID: 10905644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrocardiographic changes during acute treatment of hypertensive emergencies with sodium nitroprusside or fenoldopam.
    Gretler DD; Elliott WJ; Moscucci M; Childers RW; Murphy MB
    Arch Intern Med; 1992 Dec; 152(12):2445-8. PubMed ID: 1360793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.
    Elliott WJ; Weber RR; Nelson KS; Oliner CM; Fumo MT; Gretler DD; McCray GR; Murphy MB
    Circulation; 1990 Mar; 81(3):970-7. PubMed ID: 1968368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM.
    Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F
    Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged fenoldopam infusions in patients with mild to moderate hypertension: pharmacodynamic and pharmacokinetic effects.
    Taylor AA; Shepherd AM; Polvino W; Mangoo-Karim R; Ballard K; Sunthornyothin S; Luther RR; Pool JL
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):906-14. PubMed ID: 10509549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative acute blood pressure reduction from intravenous fenoldopam mesylate versus sodium nitroprusside in severe systemic hypertension.
    Bednarczyk EM; White WB; Munger MA; Gonzalez FM; Panacek EA; Weed SG; Rutherford WF; Nara AR; Green JA
    Am J Cardiol; 1989 Apr; 63(13):993-6. PubMed ID: 2564726
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension.
    Neutel JM; Smith DH; Wallin D; Cook E; Ram CV; Fletcher E; Maher KE; Turlepaty P; Grandy S; Lee R
    Am J Hypertens; 1994 Jul; 7(7 Pt 1):623-8. PubMed ID: 7946164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.